AstraZeneca Is Waiting to Hear From FDA on Trial Halt, CEO Says

(Bloomberg) -- AstraZeneca Plc, the drugmaker developing a potential coronavirus vaccine with the University of Oxford, said it is still waiting for a decision from U.S. regulators on whether it ca...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.